Effect evaluation of Reverse diabetes type 2 program by Voeding Leeft

Withdrawn

• Conditions: Diabetes mellitus; 10018424

• Registration Number: NL-OMON45893
• Lead Sponsor: ouis Bolk Instituut

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

All participants of the Voeding Leeft program can participate in this evaluation study.

Exclusion Criteria

None.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Self-reported HbA1c values and medication use assessed via online<br /><br>questionnaires.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Other than HbA1c self-reported T2D biomarkers, subjective health parameters,<br /><br>sleep, dietary intake, physical activity and program adherence. </p><br>